Physician

Scott Charles Leverage, MD

According to 2025 Medicare claims, Scott Leverage, MD (NPI: 1700064995) practices gastroenterology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is TRI-STATE GASTROENTEROLOGY ASSOCIATES, PSC (NPI: 1306843842; TIN: 611192347) and primary practice location at 41017-3409. Leverage is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Leverage's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 12,866 HCPCS/CPT codes, and received $198,305 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 1,485 prescription claims across 474 beneficiaries totaling $894,775 in drug costs, led by Xifaxan (Rifaximin). Open Payments data shows 138 records totaling $2,583. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $87,654 to $198,305. Similarly, Part D prescription costs have moved sharply higher in recent years, from $541,416 to $894,775. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	363	1,317	$87,654
2016	392	1,112	$80,344
2017	412	997	$84,918
2018	374	4,617	$79,221
2019	342	3,025	$72,584
2020	314	679	$58,819
2021	359	10,628	$101,485
2022	349	10,257	$107,796
2023	428	18,249	$161,595
2024	424	12,866	$198,305

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	204	1,094	$541,416
2016	216	1,253	$374,777
2017	254	1,267	$296,984
2018	248	1,157	$284,971
2019	252	1,137	$308,264
2020	271	1,135	$360,179
2021	280	1,015	$468,775
2022	333	1,205	$540,626
2023	432	1,384	$1,047,068
2024	474	1,485	$894,775

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	169	172	$132
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	57	57	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	156	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	67	76	$61
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	110	112	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xifaxan	Rifaximin	28	658	$92,211
Linzess	Linaclotide	90	4,980	$86,326
Sandostatin Lar Depot	Octreotide Acetate,mi-Spheres	13	390	$57,792
Creon	Lipase/Protease/Amylase	20	514	$33,824
Relistor	Methylnaltrexone Bromide	12	360	$27,912

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	138	$2,583	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott Charles Leverage, MD?

Tedicare shows public-source Medicare data for Scott Charles Leverage, MD (NPI 1700064995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Charles Leverage, MD have ACO affiliation data?

Scott Charles Leverage, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Scott Charles Leverage, MD?

Scott Charles Leverage, MD is linked to TRI-STATE GASTROENTEROLOGY ASSOCIATES, PSC (billing NPI 1306843842) in the available physician profile data.

Does Scott Charles Leverage, MD have Open Payments data?

Scott Charles Leverage, MD has 138 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.